CardioTech Announces CE Mark Application Submission

CardioTech International announced that it has submitted to its European Notified Body an application to obtain CE Marking approval of its CardioPass Artificial Coronary Artery Graft. Its initial indication for use will be for "no-option" patients who are in need of coronary artery bypass but do not have an adequate amount of their own native vessels that can be utilized for the necessary revascularization.

mysan.de (http://www.mysan.de/article70103.html)